Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02111785 · ClinicalTrials.gov registry record · Phase 2
Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma
A Phase 2 study, sponsored by University of Virginia.
- Terminated
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT02111785 is a Phase 2 study that was terminated before completion, run by University of Virginia. The registered enrollment target is 10 participants.
The verdict
NCT02111785, a Phase 2 study, was terminated before completion, sponsored by University of Virginia.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
Chronic subdural hematoma (cSDH) is condition where blood has slowly leaked out of small blood vessels surrounding the brain. Over time, the blood may cause a variety of symptoms including headache, confusion, limb weakness, and difficulty speaking. There is currently no agreement among physicians as to the best way to treat this condition. The study hypothesis to be tested was: For patients with unilateral, symptomatic chronic subdural hematoma, there is no difference in clinical outcomes, as measured by achievement of modified Rankin Score of 0-2 at 6 months, between those treated with a 2 week course of oral dexamethasone, compared with those treated with burr hole surgical drainage.
Interventions
- DRUG Dexamethasone
- PROCEDURE Burr Hole Craniostomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-03 |
| Est. Completion | 2017-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02111785
The ClinicalTrials.gov registry entry for NCT02111785 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT02111785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02111785 about?
NCT02111785 is a clinical study titled "Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma". Chronic subdural hematoma (cSDH) is condition where blood has slowly leaked out of small blood vessels surrounding the brain. Over time, the blood may cause a variety of symptoms including headache, confusion, limb weakness, and difficulty speaking. There is currently no agreement among physicians ...
What is the current status of trial NCT02111785?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2014-03. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02111785?
The interventions under investigation include: Dexamethasone (DRUG), Burr Hole Craniostomy (PROCEDURE).
Who is sponsoring clinical trial NCT02111785?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.